![]() |
CiteULike | ![]() |
martin-novak's CiteULike | ![]() |
![]() |
|
![]() |
Register | ![]() |
Log in | ![]() |
Synaptic plasticity: one STEP at a time. |
Reviews
[Write a review of this article]
Notes for this articleBraithwaite 2006 review
STEP = STOP to synaptic plasticity via deP of ERK, Fyn and NR2B
* STEP (STriatum Enriched tyrosin Phosphatase, PTPN5) * splice variants: cytosolic 46, membrane bound 61 (ER, PSD), several inactive variants * KIM - kinase-interactin mitif - binding MAPKs (STEP specific) * both in striatum and central amygdala X only 61 in Hipp, Cx, BLA * main effect post-synaptically, but also present pre-synaptically * D1-PKA-pSTEP (inactive)-prolonged pERK * NMDA-Ca-Calcineurin-STEP (active)-ERK dephosphorylation-STOP plasticity * Targets: MAPKs (ERK, p38alpha, JNK), Fyn, NR2B * Fyn - deP on Tyr420 causes inactivation * NR2B - pFyn-pNR2B-membrane-STEP-internalization, also reduce opening probability and time of NMDA * Alzheimer - Abeta-AchR-Ca-Calcineurin-STEP (active)- deP NR2B and deP Fyn - NMDA internalization
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
Posting History
AbstractStriatal enriched tyrosine phosphatase (STEP) has recently been identified as a crucial player in the regulation of synaptic function. It is restricted to neurons within the CNS and acts by downregulating the activity of MAP kinases, the tyrosine kinase Fyn and NMDA receptors. By modulating these substrates, STEP acts on several parallel pathways that impact upon the progression of synaptic plasticity. Here, we review recent advances that demonstrate the importance of STEP in normal cognitive function, and its possible involvement in cognitive disorders such as Alzheimer's disease.
BibTeX record
RIS record